G-protein-coupled receptor GPR161 is overexpressed in breast cancer and is a promoter of cell proliferation and invasion

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages 4191-4196

  Feigin, Michael E ^a   Xue, Bin ^a,b   Hammell, Molly C ^a   Muthuswamy, Senthil K ^a,b,c  

^a Cold Spring Harbor Laboratory ^*  (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 2; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 161; IQ MOTIF CONTAINING GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN 1; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BREAST EPITHELIUM; CANCER CELL; CANCER CELL CULTURE; CELL CULTURE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRIPLE NEGATIVE BREAST CANCER;

BASE SEQUENCE; BREAST NEOPLASMS; CELL PROLIFERATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; INDOLES; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; RECEPTORS, G-PROTEIN-COUPLED; RETROVIRIDAE;

EID: 84896528786     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320239111     Document Type: Article

References (31)

1. Morris AJ, Malbon CC (1999) Physiological regulation of G protein-linked signaling. Physiol Rev 79(4):1373-1430. (Pubitemid 29473319)
2. Feigin ME (2013) Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis. FEBS J 280(19):4729-4738.
3. Lappano R, Maggiolini M (2011) G protein-coupled receptors: Novel targets for drug discovery in cancer. Nat Rev Drug Discov 10(1):47-60.
4. Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7(2):79-94. (Pubitemid 46164746)
5. O'Hayre M, et al. (2013) The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer. Nat Rev Cancer 13(6):412-424.
6. Prickett TD, et al. (2011) Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma. Nat Genet 43(11):1119-1126.
7. Kan Z, et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466(7308):869-873.
8. Liang H, et al. (2012) Whole-exome sequencing combined with functional genomics reveals novel candidate driver cancer genes in endometrial cancer. Genome Res 22(11):2120-2129.
9. Zhao Q, et al. (2010) Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing. Genome Biol 11(11):R114.
10. Hammerman PS, et al.; Cancer Genome Atlas Research Network (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature 489(7417): 519-525.
11. Foulkes WD, Smith IE, Reis-Filho JS (2010) Triple-negative breast cancer. N Engl J Med 363(20):1938-1948.
12. Stevens KN, Vachon CM, Couch FJ (2013) Genetic susceptibility to triple-negative breast cancer. Cancer Res 73(7):2025-2030.
13. Matteson PG, et al. (2008) The orphan G protein-coupled receptor, Gpr161, encodes the vacuolated lens locus and controls neurulation and lens development. Proc Natl Acad Sci USA 105(6):2088-2093. (Pubitemid 351439469)
14. Leung T, et al. (2008) The orphan G protein-coupled receptor 161 is required for leftright patterning. Dev Biol 323(1):31-40.
15. Mukhopadhyay S, et al. (2013) The ciliary G-protein-coupled receptor Gpr161 negatively regulates the Sonic hedgehog pathway via cAMP signaling. Cell 152(1-2): 210-223.
16. Johannessen CM, et al. (2013) A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature 504(7478):138-142.
17. Debnath J, Muthuswamy SK, Brugge JS (2003) Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30(3):256-268. (Pubitemid 36677560)
18. Sancak Y, et al. (2007) PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25(6):903-915. (Pubitemid 46436534)
19. White CD, Erdemir HH, Sacks DB (2012) IQGAP1 and its binding proteins control diverse biological functions. Cell Signal 24(4):826-834.
20. Alemayehu M, et al. (2013) β-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1. PLoS ONE 8(2): e56174.
21. Jadeski L, Mataraza JM, Jeong HW, Li Z, Sacks DB (2008) IQGAP1 stimulates proliferation and enhances tumorigenesis of human breast epithelial cells. J Biol Chem 283(2):1008-1017.
22. Noritake J, Watanabe T, Sato K, Wang S, Kaibuchi K (2005) IQGAP1: A key regulator of adhesion and migration. J Cell Sci 118(Pt 10):2085-2092. (Pubitemid 40872832)
23. Hayashi H, et al. (2010) Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion. Int J Cancer 126(11): 2563-2574.
24. Osman MA, Sarkar FH, Rodriguez-Boulan E (2013) A molecular rheostat at the interface of cancer and diabetes. Biochim Biophys Acta 1836(1):166-176.
25. Grohmanova K, et al. (2004) Phosphorylation of IQGAP1 modulates its binding to Cdc42, revealing a new type of rho-GTPase regulator. J Biol Chem 279(47):48495-48504. (Pubitemid 39625723)
26. Wang JB, Sonn R, Tekletsadik YK, Samorodnitsky D, OsmanMA (2009) IQGAP1 regulates cell proliferation through a novel CDC42-mTOR pathway. J Cell Sci 122(Pt 12):2024-2033.
27. Tekletsadik YK, Sonn R, Osman MA (2012) A conserved role of IQGAP1 in regulating TOR complex 1. J Cell Sci 125(Pt 8):2041-2052.
28. White CD, Li Z, Dillon DA, Sacks DB (2011) IQGAP1 protein binds human epidermal growth factor receptor 2 (HER2) and modulates trastuzumab resistance. J Biol Chem 286(34):29734-29747.
29. Feigin M (2013) Harnessing the genome for characterization of G-protein coupled receptors in cancer pathogenesis. FEBS J 280(19):4729-4738.
30. Ory DS, Neugeboren BA, Mulligan RC (1996) A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci USA 93(21):11400-11406. (Pubitemid 26347133)
31. Zhan L, et al. (2008) Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135(5):865-878.